Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis

Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: Results of a longitudinal study

(2015) Filipe Nery et al.   HEPATOLOGY

Treatment of acute portal vein thrombosis by nontraditional anticoagulation

(2014) Melissa Martinez et al.   HEPATOLOGY

Efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis in patients with liver cirrhosis

(2014) Noriaki Naeshiro et al.   HEPATOLOGY RESEARCH

Established and new-generation antithrombotic drugs in patients with cirrhosis – Possibilities and caveats

(2013) Ton Lisman et al.   JOURNAL OF HEPATOLOGY

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

(2013) Christian T Ruff et al.   LANCET

Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism

(2013)   NEW ENGLAND JOURNAL OF MEDICINE

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

(2013) Robert P. Giugliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

Successful treatment of acute portal vein thrombosis with rivaroxaban

(2013) Sven Pannach et al.   THROMBOSIS AND HAEMOSTASIS

Efficacy and Safety of Anticoagulation on Patients With Cirrhosis and Portal Vein Thrombosis

(2012) María Gabriela Delgado et al.   Clinical Gastroenterology and Hepatology

Enoxaparin Prevents Portal Vein Thrombosis and Liver Decompensation in Patients With Advanced Cirrhosis

(2012) Erica Villa et al.   GASTROENTEROLOGY

Prospective evaluation of anticoagulation and transjugular intrahepatic portosistemic shunt for the management of portal vein thrombosis in cirrhosis

(2012) Marco Senzolo et al.   LIVER INTERNATIONAL

Management consensus guidance for the use of rivaroxaban – an oral, direct factor Xa inhibitor

(2012) A. G. G. Turpie et al.   THROMBOSIS AND HAEMOSTASIS

Management of Nonneoplastic Portal Vein Thrombosis in the Setting of Liver Transplantation

(2012) Kryssia I. Rodríguez-Castro et al.   TRANSPLANTATION

Effect of edoxaban on markers of coagulation in venous and shed blood compared with fondaparinux

(2011) Meyer Samama et al.   THROMBOSIS AND HAEMOSTASIS

Clinical Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Factor Xa Inhibitor Edoxaban in Healthy Volunteers

(2010) Koichiro Ogata et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Systematic review: portal vein thrombosis in cirrhosis

(2009) E. A. TSOCHATZIS et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Portal vein thrombosis, revisited

(2009) Massimo Primignani   DIGESTIVE AND LIVER DISEASE

An Imbalance of Pro- vs Anti-Coagulation Factors in Plasma From Patients With Cirrhosis

(2009) Armando Tripodi et al.   GASTROENTEROLOGY

Portal vein thrombosis and survival in patients with cirrhosis

(2009) Michael J. Englesbe et al.   LIVER TRANSPLANTATION

Vascular disorders of the liver

(2008) Laurie D. DeLeve et al.   HEPATOLOGY